Therapy-related B-lymphoblastic leukemia after multiple myeloma
Michael E Kallen1, Rima Koka1, Zeba N Singh1
1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States.
Leukemia Research Reports
|November 10, 2022
Summary
New multiple myeloma therapies can lead to secondary cancers. This study details eight cases of therapy-related B-lymphoblastic leukemia (t-B-ALL) following multiple myeloma treatment, noting good response rates to B-ALL therapy.
Area of Science:
- Hematology
- Oncology
Background:
- Novel therapies for multiple myeloma have improved patient outcomes.
- However, these treatments are associated with an increased risk of therapy-related hematologic malignancies.
Observation:
- This report describes eight patients who developed therapy-related B-lymphoblastic leukemia (t-B-ALL) after undergoing treatment for multiple myeloma.
- Lenalidomide maintenance was part of the treatment regimen for these patients.
- A subset of these patients presented with pancytopenia and minimal bone marrow involvement by acute leukemia, which is atypical for de novo B-ALL.
Findings:
- The study suggests that t-B-ALL is typically not clonally related to the original multiple myeloma.
- Patients with t-B-ALL exhibited diverse cytogenetic abnormalities.
- Seven out of eight patients responded positively to standard B-ALL therapy, with no deaths attributed to B-ALL within the median follow-up period of 1.0 year.
Implications:
- Therapy-related B-lymphoblastic leukemia is a potential complication of multiple myeloma treatment.
- Early recognition and appropriate B-ALL-directed therapy can lead to favorable outcomes in patients with t-B-ALL.
- Further research into the mechanisms and management of t-B-ALL is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:22Bone Marrow Sampling and Transplants
396
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
396
01:27Tumor Immunotherapy
638
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
638